Rebecca Critchley Thorne
About Rebecca Critchley Thorne
Rebecca Critchley Thorne serves as the Vice President of Research and Development for Spatialomics and Gastrointestinal at Castle Biosciences, Inc. in Pittsburgh, Pennsylvania, where she has worked since 2021, bringing extensive experience in cancer biology and gastroenterology research.
Work at Castle Biosciences
Rebecca Critchley Thorne serves as the Vice President of Research and Development for Spatialomics and Gastrointestinal (GI) at Castle Biosciences, Inc. since 2021. In this role, she focuses on advancing research initiatives related to Spatialomics and GI health. Her work involves conducting research that contributes to the development of innovative diagnostic solutions. Thorne's expertise in pathology assays and her background in gastroenterology research play a significant role in her contributions to the company's projects.
Education and Expertise
Rebecca Critchley Thorne has a strong academic background in pharmacology and cancer biology. She earned her Bachelor of Science with Honors in Pharmacology from The University of Sheffield from 1997 to 2000. She then pursued a Ph.D. in Cancer Biology at Imperial College London from 2000 to 2003. Following her doctoral studies, she completed a postdoctoral fellowship in Cancer Immunology at Stanford University from 2003 to 2007. This extensive education has equipped her with the knowledge and skills necessary for her research and development roles.
Previous Experience in Research and Development
Before her current position, Rebecca Critchley Thorne held significant roles in various organizations. She worked as a Senior Scientist at Cellumen, Inc. for nine months in 2007. Subsequently, she served as Chief Scientific Officer at Cernostics, Inc. from 2008 to 2021, where she led scientific initiatives and research projects. Additionally, her experience as a Postdoctoral Scholar at Stanford University from 2003 to 2007 provided her with foundational research skills in cancer immunology.
Research Contributions
Rebecca Critchley Thorne has conducted notable research on TissueCypher Barrett's Esophagus, focusing on its implications for clinical decision-making. She has authored studies that examine the impact of TissueCypher on pathology assays for Barrett's Esophagus. Her research contributions are significant in the field of gastroenterology, enhancing understanding and treatment options for related conditions.